Ameritas Investment Partners’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Ameritas Investment Partners’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,532	Closed	-$98K	–	3012
2018 Q3	$98K	Hold	5,532	–	–	﹤0.01%	1592
2018 Q2	$76K	Buy	+5,532	New	+$65.7K	﹤0.01%	1726
2017 Q2	–	Sell	-2,665	Closed	-$7K	–	3097
2017 Q1	$7K	Buy	+2,665	New	+$6.17K	﹤0.01%	2799

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Ameritas Investment Partners's ECYT Position: Q4 2018 in Review

Ameritas Investment Partners sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 5,532 shares — an estimated $98K sold.

Ameritas Investment Partners first reported a position in ECYT in Q1 2017 and held it in 3 quarters. The position peaked at $98K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Ameritas Investment Partners reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Ameritas Investment Partners sold 5,532 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $98K.
Ameritas Investment Partners first reported a position in Endocyte, Inc. Common Stock in Q1 2017 and held it in 3 quarters.
Ameritas Investment Partners's Endocyte, Inc. Common Stock position peaked at $98K in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Ameritas Investment Partners's 13F filing for Q4 2018, filed 12 Feb 2019.